Myriam Curet serves as Director of Mobia Medical, Inc. (MOBI). Curet has also held reporting roles at Stereotaxis, Inc. (STXS) and Inspire Medical Systems, Inc. (INSP). Curet has reported 20 insider filings with the SEC since 2024. The most recent filing was in August 2026.
Every role Myriam Curet has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Updated Aug 30, 2026
Myriam Curet is Director of Mobia Medical, Inc. (MOBI). 19 SEC Form 4 filings on record going back to 2024, most recently on 3 August 2026. Most recent open-market trade: sold $52K of ISRG on 11 March 2026. Lifetime open-market purchases: $804. Lifetime open-market sales: $19.87M.
Every recent SEC Form 4 transaction Myriam Curet has reported, most recent first.
InsiderAlpha's records for Myriam Curet go back to 2024: 19 primary Form 4 filings, an average of 6.3 per year. The typical open-market purchase is $402 (2 buys totaling $804). The largest single buy on record is $655 of INSP in 2025. Sales side: 23 recorded sales totaling $19.87M, so the filing history runs sell-heavy by dollar value. 61 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Myriam Curet files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Myriam Curet is a corporate insider, tracked as Director of Mobia Medical, Inc. (MOBI). InsiderAlpha holds 19 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($804) and 23 open-market sales ($19.87M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
105 shares @ $493.95$52K